109 related articles for article (PubMed ID: 28368904)
21. Evaluation of the cytotoxic effect of camptothecin solid lipid nanoparticles on MCF7 cells.
Acevedo-Morantes CY; Acevedo-Morantes MT; Suleiman-Rosado D; Ramírez-Vick JE
Drug Deliv; 2013 Nov; 20(8):338-48. PubMed ID: 24024505
[TBL] [Abstract][Full Text] [Related]
22. Preparation and antitumor study of camptothecin nanocrystals.
Zhang H; Hollis CP; Zhang Q; Li T
Int J Pharm; 2011 Aug; 415(1-2):293-300. PubMed ID: 21679755
[TBL] [Abstract][Full Text] [Related]
23. Development and evaluation of camptothecin loaded polymer stabilized nanoemulsion: Targeting potential in 4T1-breast tumour xenograft model.
Sugumaran A; Ponnusamy C; Kandasamy P; Krishnaswami V; Palanichamy R; Kandasamy R; Lakshmanan M; Natesan S
Eur J Pharm Sci; 2018 Apr; 116():15-25. PubMed ID: 28987538
[TBL] [Abstract][Full Text] [Related]
24. Novel Hydrophilic Camptothecin Derivatives Conjugated to Branched Glycerol Trimer Suppress Tumor Growth without Causing Diarrhea in Murine Xenograft Models of Human Lung Cancer.
Tsuchihashi Y; Abe S; Miyamoto L; Tsunematsu H; Izumi T; Hatano A; Okuno H; Yamane M; Yasuoka T; Ikeda Y; Tsuchiya K
Mol Pharm; 2020 Apr; 17(4):1049-1058. PubMed ID: 32068412
[TBL] [Abstract][Full Text] [Related]
25. Preparation of camptothecin-loaded polymeric micelles and evaluation of their incorporation and circulation stability.
Watanabe M; Kawano K; Yokoyama M; Opanasopit P; Okano T; Maitani Y
Int J Pharm; 2006 Feb; 308(1-2):183-9. PubMed ID: 16324807
[TBL] [Abstract][Full Text] [Related]
26. Preparation of camptothecin-loaded targeting nanoparticles and their antitumor effects on hepatocellular carcinoma cell line H22.
Yang A; Liu Z; Yan B; Zhou M; Xiong X
Drug Deliv; 2016 Jun; 23(5):1699-706. PubMed ID: 25148540
[TBL] [Abstract][Full Text] [Related]
27. Camptothecin analogues with enhanced antitumor activity at acidic pH.
Adams DJ; Dewhirst MW; Flowers JL; Gamcsik MP; Colvin OM; Manikumar G; Wani MC; Wall ME
Cancer Chemother Pharmacol; 2000; 46(4):263-71. PubMed ID: 11052623
[TBL] [Abstract][Full Text] [Related]
28. Nanofibrous silica microparticles/polymer hybrid aerogels for sustained delivery of poorly water-soluble camptothecin.
Follmann HDM; Oliveira ON; Martins AC; Lazarin-Bidóia D; Nakamura CV; Rubira AF; Silva R; Asefa T
J Colloid Interface Sci; 2020 May; 567():92-102. PubMed ID: 32036118
[TBL] [Abstract][Full Text] [Related]
29. Amorphous solid dispersion studies of camptothecin-cyclodextrin inclusion complexes in PEG 6000.
Fatmi S; Bournine L; Iguer-Ouada M; Lahiani-Skiba M; Bouchal F; Skiba M
Acta Pol Pharm; 2015; 72(1):179-92. PubMed ID: 25850214
[TBL] [Abstract][Full Text] [Related]
30. In vivo antitumor activity of camptothecin incorporated in liposomes formulated with an artificial lipid and human serum albumin.
Watanabe M; Kawano K; Toma K; Hattori Y; Maitani Y
J Control Release; 2008 May; 127(3):231-8. PubMed ID: 18384903
[TBL] [Abstract][Full Text] [Related]
31. Water soluble 20(S)-glycinate esters of 10,11-methylenedioxycamptothecins are highly active against human breast cancer xenografts.
Wadkins RM; Potter PM; Vladu B; Marty J; Mangold G; Weitman S; Manikumar G; Wani MC; Wall ME; Von Hoff DD
Cancer Res; 1999 Jul; 59(14):3424-8. PubMed ID: 10416605
[TBL] [Abstract][Full Text] [Related]
32. Investigation of parameters influencing incorporation, retention and cellular cytotoxicity in liposomal formulations of poorly soluble camptothecin.
Whitaker RD; Ingebrigtsen SG; Naderkhani E; Skar ML; Flaten GE
J Liposome Res; 2013 Dec; 23(4):298-310. PubMed ID: 23763495
[TBL] [Abstract][Full Text] [Related]
33. Improved dissolution and cytotoxicity of camptothecin incorporated into oxidized-cellulose microspheres prepared by spray drying.
Kumar V; Kang J; Hohl RJ
Pharm Dev Technol; 2001 Aug; 6(3):459-67. PubMed ID: 11485187
[TBL] [Abstract][Full Text] [Related]
34. Mixed micelles made of poly(ethylene glycol)-phosphatidylethanolamine conjugate and d-alpha-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin.
Mu L; Elbayoumi TA; Torchilin VP
Int J Pharm; 2005 Dec; 306(1-2):142-9. PubMed ID: 16242875
[TBL] [Abstract][Full Text] [Related]
35. Efficiency of newly formulated camptothecin with β-cyclodextrin-EDTA-Fe
Krishnan P; Rajan M; Kumari S; Sakinah S; Priya SP; Amira F; Danjuma L; Pooi Ling M; Fakurazi S; Arulselvan P; Higuchi A; Arumugam R; Alarfaj AA; Munusamy MA; Hamat RA; Benelli G; Murugan K; Kumar SS
Sci Rep; 2017 Sep; 7(1):10962. PubMed ID: 28887536
[TBL] [Abstract][Full Text] [Related]
36. SDS-aided immobilization and controlled release of camptothecin from agarose hydrogel.
Liu J; Li L
Eur J Pharm Sci; 2005 Jun; 25(2-3):237-44. PubMed ID: 15911219
[TBL] [Abstract][Full Text] [Related]
37. Aspergillus terreus camptothecin-sodium alginate/titanium dioxide nanoparticles as a novel nanocomposite with enhanced compatibility and anticancer efficiency in vivo.
Kelany NA; El-Sayed ASA; Ibrahim MA
BMC Biotechnol; 2023 Apr; 23(1):9. PubMed ID: 37005635
[TBL] [Abstract][Full Text] [Related]
38. Novel SN38 conjugate-forming nanoparticles as anticancer prodrug: in vitro and in vivo studies.
Zhang H; Wang J; Mao W; Huang J; Wu X; Shen Y; Sui M
J Control Release; 2013 Mar; 166(2):147-58. PubMed ID: 23266448
[TBL] [Abstract][Full Text] [Related]
39. Enhanced Liver Targeting of Camptothecin via Conjugation with Deoxycholic Acid.
Xiao L; Yu E; Yue H; Li Q
Molecules; 2019 Mar; 24(6):. PubMed ID: 30917485
[TBL] [Abstract][Full Text] [Related]
40. Camptothecin and its analogues: a review on their chemotherapeutic potential.
Sriram D; Yogeeswari P; Thirumurugan R; Bal TR
Nat Prod Res; 2005 Jun; 19(4):393-412. PubMed ID: 15938148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
